beta-thujaplicinol has been researched along with 3-hydroxy-quinazoline-2,4-dione in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balakrishnan, M; Barnes, T; Brendza, KM; Chen, X; Eisenberg, EJ; Jin, W; Kirschberg, TA; Kutty, N; Lansdon, EB; Leavitt, S; Liclican, A; Liu, Q; Liu, X; Mak, J; Perry, JK; Squires, NH; Wang, M; Watkins, WJ | 1 |
1 other study(ies) available for beta-thujaplicinol and 3-hydroxy-quinazoline-2,4-dione
| Article | Year |
|---|---|
RNase H active site inhibitors of human immunodeficiency virus type 1 reverse transcriptase: design, biochemical activity, and structural information.
Topics: Carboxylic Acids; Catalytic Domain; Drug Design; HIV Reverse Transcriptase; Humans; Protein Binding; Pyrimidines; Ribonuclease H | 2009 |